Prostate News and Research

RSS

Sedentary behaviour has unclear link with prostate cancer risk

Sedentary behaviour is not a clearcut risk factor for prostate cancer, analysis of a large population-based cohort indicates.

25 Feb 2014

AMIC provides report on FDA pre-market notification related to brachytherapy cancer product

Advanced Medical Isotope Corporation ("AMIC"), a company engaged in the development, production and distribution of medical isotopes focused on yttrium-90 brachytherapy devices, today announced that it has received a response from the FDA to its pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for its Yttrium-90 (Y-90) RadioGel(tm) patented brachytherapy cancer product.

25 Feb 2014

Research could lead to early diagnosis and treatment of prostate cancer

Prostate cancer patients could get better diagnosis and treatment for the disease in the future thanks to a successful research project at the University of Essex.

25 Feb 2014

Enzalutamide shows added benefit in prostate cancer patients without visceral metastases

Enzalutamide (trade name: Xtandi) has been approved since June 2013 for men with metastatic prostate cancer in whom the commonly used hormone blockade is no longer effective and who have already been treated with the cytostatic drug docetaxel.

25 Feb 2014

Vitamin E supplements and selenium may increase prostate cancer risk

In a large clinical trial testing dietary supplements for prostate cancer (PCa) prevention, baseline selenium (Se) status (measured by toenail Se concentration), in the absence of supplementation, was not associated with prostate cancer (PCa) risk.

24 Feb 2014

Epidemiological studies demonstrate that diseases of central nervous system protect against cancer

Epidemiological studies demonstrate that diseases of the central nervous system such as Alzheimer, Parkinson and schizophrenia protect against cancer. The most remarkable example is Alzheimer's disease, which can reduce the risk of suffering from cancer by up to 50%.

21 Feb 2014

Certain fragments of DNA shed by tumors can be used to non-invasively screen for early-stage cancers

Certain fragments of DNA shed by tumors into the bloodstream can potentially be used to non-invasively screen for early-stage cancers, monitor responses to treatment and help explain why some cancers are resistant to therapies, according to results of an international study led by Johns Hopkins Kimmel Cancer Center investigators.

20 Feb 2014

Researchers receive $3M grant to develop targeted cancer drugs and repair damaged arteries

The National Institutes of Health has awarded grants totaling $3 million for two nanoparticle research projects in which Penn State bioengineer Jian Yang is co-principal investigator.

19 Feb 2014

Researchers find 'missing' genetic risk in cancer

A new study could help to answer an important riddle in our understanding of genetics: why research to look for the genetic causes of common diseases has failed to explain more than a fraction of the heritable risk of developing them.

14 Feb 2014

TPI announces financial results for second quarter fiscal year 2014

Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the second quarter fiscal year 2014.

14 Feb 2014

Researchers offer new options for men whose prostate cancer has spread to bones

Dartmouth-Hitchcock Norris Cotton Cancer Center has treated three men with a recently FDA-approved treatment, which offers new options for men whose prostate cancer has spread to their bones.

13 Feb 2014

Understanding genetic changes associated with aggressive prostate cancer

Researchers at the University of East Anglia have made an important advance in understanding genetic changes associated with terminal prostate cancer.

12 Feb 2014

Mayo Clinic researchers shed light on new mechanism by which prostate cancer develops in men

Mayo Clinic researchers have shed light on a new mechanism by which prostate cancer develops in men. Central to development of nearly all prostate cancer cases are malfunctions in the androgen receptor - the cellular component that binds to male hormones.

11 Feb 2014

Mild LUTS associated with storage symptoms in men

Researchers from Taiwan have found that the International Prostate Symptom Score can differentiate between men with bladder storage dysfunction and those with bladder outlet disorders.

10 Feb 2014

New combination MRI-ultrasound imaging system improves treatment for prostate cancer patients

A new combination MRI-ultrasound imaging system can result in fewer biopsies and better treatment decisions for prostate cancer patients.

10 Feb 2014

Immunology professor receives 2014 Szent-Györgyi Prize for progress in cancer research from NFCR

Discovering key elements of immune system T cell biology and applying that knowledge to create a new way to treat cancer has earned Jim Allison, Ph.D., the 2014 Szent-Györgyi Prize for Progress in Cancer Research from the National Foundation for Cancer Research.

10 Feb 2014

Ipsen’s phase III clinical trial evaluating Decapeptyl in patients with prostate cancer meets primary endpoints

Ipsen today announced that the phase III clinical trial evaluating Decapeptyl (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with locally advanced or metastatic prostate cancer has met its primary endpoints.

10 Feb 2014

Findings could open door to development of new therapies for treatment of prostate cancer

SCIENTISTS at the University of York have discovered how the prostate gland develops for the first time, according to research published today (Thursday, February 6) in Stem Cell Reports.

7 Feb 2014

Invasive 3D mapping biopsies detect ultrasound-guided biopsies miss prostate cancers

Ultrasound-guided biopsies miss prostate cancers that are detected by the slightly more expensive and slightly more invasive 3D mapping biopsies. For example, in a 2006 study of 180 men diagnosed with early stage prostate cancer via ultrasound-guided biopsy, nearly a quarter were upgraded to a more clinically significant stage of disease after 3D mapping biopsy found pockets of cancer the first technique had missed.

5 Feb 2014

Research: SSeCKS/AKAP12 gene key inhibitor of prostate cancer metastasis

New evidence reported by researchers at Roswell Park Cancer Institute (RPCI) lends support to the hypothesis that the SSeCKS/AKAP12 gene is a key inhibitor of prostate cancer metastasis.

4 Feb 2014

Prostate News and Research

Sedentary behaviour has unclear link with prostate cancer risk

AMIC provides report on FDA pre-market notification related to brachytherapy cancer product

Research could lead to early diagnosis and treatment of prostate cancer

Enzalutamide shows added benefit in prostate cancer patients without visceral metastases

Vitamin E supplements and selenium may increase prostate cancer risk

Epidemiological studies demonstrate that diseases of central nervous system protect against cancer

Certain fragments of DNA shed by tumors can be used to non-invasively screen for early-stage cancers

Researchers receive $3M grant to develop targeted cancer drugs and repair damaged arteries

Researchers find 'missing' genetic risk in cancer

TPI announces financial results for second quarter fiscal year 2014

Researchers offer new options for men whose prostate cancer has spread to bones

Understanding genetic changes associated with aggressive prostate cancer

Mayo Clinic researchers shed light on new mechanism by which prostate cancer develops in men

Mild LUTS associated with storage symptoms in men

New combination MRI-ultrasound imaging system improves treatment for prostate cancer patients

Immunology professor receives 2014 Szent-Györgyi Prize for progress in cancer research from NFCR

Ipsen’s phase III clinical trial evaluating Decapeptyl in patients with prostate cancer meets primary endpoints

Findings could open door to development of new therapies for treatment of prostate cancer

Invasive 3D mapping biopsies detect ultrasound-guided biopsies miss prostate cancers

Research: SSeCKS/AKAP12 gene key inhibitor of prostate cancer metastasis

What to know about prostate cancer eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News